Loading Live Market Data...
Culture & Arts

Megan Fox flaunts her curves in a red catsuit as she fronts ad campaign for erectile dysfunction medication

Daily Mail•3 min read•Oct 2, 2026•Updated: 11d ago•REF: OPA-261002-9H7
Megan Fox flaunts her curves in a red catsuit as she fronts ad campaign for erectile dysfunction medication

Key Takeaways

  • Megan Fox is the new face of a pharmaceutical campaign for erectile dysfunction medication by the brand Ro.
  • Fox aims to remove the stigma surrounding men's sexual performance, arguing that virility is often tied to male identity.
  • The actress is reportedly returning for a sequel to her 2009 cult horror film, Jennifer's Body, alongside the original creative team.
Listen to Article0%
Share Story

Megan Fox, the 40-year-old mother of four and renowned actress, has taken on a surprising new role as the face of a pharmaceutical advertising campaign for erectile dysfunction medication by the brand Ro. Appearing in a series of promotional materials, including a commercial and a professional photoshoot, Fox is seen wearing a striking, skin-tight red catsuit. This partnership marks a significant shift in her career trajectory, moving away from traditional film roles to become a prominent spokesperson for a health-focused brand targeting male sexual wellness.

Discussing the collaboration with People magazine, Fox emphasized that she felt she was the ideal person to champion this cause. She stated that her primary goal is to dismantle the stigma and societal pressure surrounding men's sexual performance. Fox noted that while women are constantly subjected to unrealistic beauty standards regarding their appearance and youth, men often tie their entire sense of identity, ego, and masculinity to their sexual virility. By speaking openly about the prevalence of erectile dysfunction, she hopes to encourage better education and reduce the taboo nature of the condition.

Fox's career has been diverse, ranging from her breakout role in the 2009 horror cult classic Jennifer's Body to her recent performance in the 2024 erotic sci-fi thriller Subservience. Despite her reputation for risqué style, she has historically been selective about her roles, previously expressing concerns about filming graphic scenes that might be inappropriate for her children to witness. However, her recent work in Subservience and her new role with Ro suggest a more open approach to her public image and the types of projects she chooses to associate with in the current entertainment landscape.

The implications of this campaign are significant, as it bridges the gap between celebrity culture and medical marketing. Industry insiders have previously speculated on the immense financial potential Fox could command if she were to pivot toward platforms like OnlyFans, with estimates suggesting she could earn over $10 million monthly due to her massive global reach. While she has not pursued that path, her involvement in this pharmaceutical campaign highlights her continued status as a high-value commodity for brands looking to leverage her fame to normalize sensitive health topics.

Looking ahead, fans of the actress have much to anticipate, as reports from Dread Central indicate that Fox is officially on board for a sequel to the 2009 hit Jennifer's Body. With original director Karyn Kusama and writer Diablo Cody returning to helm the project, the sequel is expected to generate significant buzz. As Fox balances her acting career with high-profile brand endorsements, her ability to remain relevant in both the film industry and the commercial sector underscores her enduring influence as a global cultural icon.

Share Story

Reader Discussion

Leave a Comment

0 Comments

Loading comments...

MK
Mohammad KaramaliStaff JournalistToronto, Canada

Owner

OWNER

Editorial Oversight & Machine-Assisted Reporting

Human-in-the-Loop Verified

Editorial Oversight & Machine-Assisted Reporting: This dispatch was synthesized and localized via OPA automated intelligence under continuous human editorial supervision.

Wire Source

This report was synthesized from Daily Mail under journalistic fair use.